The number of people with susceptibility test result for rifampicin in Indonesia
Indonesia: The number of people with susceptibility test result for rifampicin was 72.55 in 2021. ▲ Rising
Latest (2021)
72.55
Change on year
up 26.0%
World rank
102nd
of 146 countries
All-time high
72.55
in 2021
All-time low
8.53
in 2017
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Indonesia, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
Indonesia recorded 72.55 for the number of people with susceptibility test result for rifampicin in 2021. That is the highest value across all 5 years on record.
That represents a change of up 26.0% on the previous year and up 750.7% over five years.
Indonesia ranks 102nd of 146 countries on this measure, in the middle of the range.
The number of people with susceptibility test result for rifampicin in Indonesia, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 8.53 | — |
| 2018 | 32.73 | +283.8% |
| 2019 | 51.25 | +56.6% |
| 2020 | 57.57 | +12.3% |
| 2021 | 72.55 | +26.0% |
Indonesia compared with similar countries
- Indonesia's 72.55 is below the median for upper middle income countries, which is 92.7, 78% of the median. (45 countries reporting)
- Indonesia's 72.55 is below the median for East Asia & Pacific, which is 96.47, 75% of the median. (28 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 30.84 | 8.53 | 51.25 | 3 |
| 2020s | 65.06 | 57.57 | 72.55 | 2 |
Countries ranked near Indonesia
- 99 Thailand 76.11 compare
- 100 Nigeria 76 compare
- 101 Uganda 74.76 compare
- 103 Afghanistan 70.58 compare
- 104 United Arab Emirates 69.7 compare
- 105 Cape Verde 69.01 compare
More health data for Indonesia
- Un projection of annual infant deaths, annual growth rate -1.35 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.4924 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,286 deaths per 1,000 people (2090)
- Number of infants who die before age 1 16,463 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 50 (2025)
- Population ages 00-04, female, annual growth rate -0.5792 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0376 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.5519 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Indonesia?
- The number of people with susceptibility test result for rifampicin in Indonesia was 72.55 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Indonesia?
- The highest recorded value was 72.55 in 2021.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Indonesia?
- The lowest recorded value was 8.53 in 2017.
- How does Indonesia rank for the number of people with susceptibility test result for rifampicin?
- Indonesia ranks 102nd out of 146 countries with data for 2021.
- Where does this Indonesia data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).